Extreme polyvalency induces potent cross-clade cellular and humoral responses in rabbits and non-human primates
US11883484B2 · kind B2 · utility
0Cited by
3References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 10, 2020 |
| Grant date | Jan 30, 2024 |
| Priority date | — |
| Expiry date | Nov 10, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16171
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions comprising two or more DNA plasmids encoding consensus and transmitted founder HIV envelope glycoproteins which expressed and induce a potent immune response.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.